About Lonza Biologics plc
Lonza Biologics is one the world leaders in development and manufacturing of monoclonal antibodies and recombinant proteins using mammalian cell culture. Biologics forms part of the custom manufacturing division of Lonza Group, a Swiss SIX Exchange quoted company, with other divisions supplying chemical and biotech ingredients to the nutrition, hygiene, preservation, agricultural and personal care markets.
“You participate in all aspects of the business, which provides lots of variety”
“Lonza recognises talent and gives responsibility to those who show ability; after six years here I now run the team I initially joined.
“The culture here is very open. You participate in all aspects of the business, which provides lots of variety, and if you have a good idea that will benefit the company you’re given the responsibility and authority to implement it.
“If staff show knowledge and ability in their field, they quickly find themselves talking to clients from some of the world’s largest pharmaceutical companies, implementing new technology or new ways of working and playing a key role in the success of the business.”
Mark Davies, QC microbiology manager, joined January 2004